Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M117,083Revenue $M17,729Net Margin (%)-14.3Altman Z-Score1.2
Enterprise Value $M161,811EPS $-9.4Operating Margin %-12.2Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.3Pre-tax Margin (%)-18.0Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales5.15-y EBITDA Growth Rate %3.8Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow33.6y-y EBITDA Growth Rate %-49.6ROA % (ttm)-3.1Higher Current Ratio y-yN
Dividend Yield %0.1PEG--ROE % (ttm)-6.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M394ROIC % (ttm)-2.8Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNJohn Paulson 2015-06-30 Add2.21%$282.86 - $313.08
($298.2)
$ 297.44-0%Add 27.18%7,174,200
AGNJulian Robertson 2015-06-30 Reduce-1.4%$282.86 - $313.08
($298.2)
$ 297.44-0%Reduce 38.62%44,500
AGNGeorge Soros 2015-06-30 Reduce-0.85%$282.86 - $313.08
($298.2)
$ 297.44-0%Reduce 61.82%159,338
AGNSteve Mandel 2015-06-30 Add0.53%$282.86 - $313.08
($298.2)
$ 297.44-0%Add 25.41%2,297,966
AGNPrivate Capital 2015-06-30 Add0.23%$282.86 - $313.08
($298.2)
$ 297.44-0%Add 4.45%165,927
AGNLeon Cooperman 2015-06-30 Reduce-0.05%$282.86 - $313.08
($298.2)
$ 297.44-0%Reduce 1.19%922,375
AGNFirst Eagle Investment 2015-06-30 Reduce-0.02%$282.86 - $313.08
($298.2)
$ 297.44-0%Reduce 1.73%1,546,324
AGNKen Fisher 2015-06-30 Add$282.86 - $313.08
($298.2)
$ 297.44-0%Add 10.73%3,580
AGNMario Gabelli 2015-06-30 Add$282.86 - $313.08
($298.2)
$ 297.44-0%Add 6.07%37,286
AGNJohn Keeley 2015-06-30 Buy $282.86 - $313.08
($298.2)
$ 297.44-0%New holding660
AGNChris Davis 2015-06-30 Buy $282.86 - $313.08
($298.2)
$ 297.44-0%New holding2,100
AGNDodge & Cox 2015-06-30 Reduce$282.86 - $313.08
($298.2)
$ 297.44-0%Reduce 0.06%1,601
AGNBill Ackman 2015-03-31 Sold Out -35.3%$209.37 - $240.22
($225.95)
$ 297.4432%Sold Out0
AGNJohn Paulson 2015-03-31 Sold Out -7%$209.37 - $240.22
($225.95)
$ 297.4432%Sold Out0
AGNJohn Paulson 2015-03-31 Add6.37%$255.17 - $317.06
($285.1)
$ 297.444%Add 261.45%5,640,788
AGNJulian Robertson 2015-03-31 Buy 3.62%$255.17 - $317.06
($285.1)
$ 297.444%New holding72,500
AGNBill Ackman 2015-03-31 Buy 2.68%$255.17 - $317.06
($285.1)
$ 297.444%New holding1,348,358
AGNSteve Mandel 2015-03-31 Buy 2.06%$255.17 - $317.06
($285.1)
$ 297.444%New holding1,832,314
AGNGeorge Soros 2015-03-31 Sold Out -1.1%$209.37 - $240.22
($225.95)
$ 297.4432%Sold Out0
AGNFirst Eagle Investment 2015-03-31 Sold Out -0.33%$209.37 - $240.22
($225.95)
$ 297.4432%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BISARO PAULExec Chairman 2015-08-24Buy1,000$297.420.01view
SAUNDERS BRENT LCEO and President 2015-08-21Buy1,000$301.94-1.49view
Basgoz NesliDirector 2015-06-09Sell2,200$297.89-0.15view
Meury WilliamSee Remarks 2014-11-26Sell4,550$269.1410.51view
PAONESSA ALBERT IIIPresident Anda, Inc. 2014-09-08Sell6,642$230.4929.05view
Hindman James M.EVP, Finance & Bus. Dev., CFO 2014-08-18Sell0$029.05view
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.8290.89view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.79136.46view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.7136.63view
HUDSON DAWN EDirector 2014-02-19Sell4,200$126.35135.41view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

    News about AGN:

    Articles On GuruFocus.com
    Sheets Smith Wealth Management Buys Companies With no Debts Sep 01 2015 
    Moody Lynn & Lieberson Top Buys in Second Quarter Aug 27 2015 
    A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals Aug 25 2015 
    Kelly Lawrence W & Associates' Top Buys of Q2 2015 Aug 24 2015 
    Allergan, Google Among Popular Guru Stocks Aug 18 2015 
    M&R Capital Management Buys Allergan in Q2 2015 Aug 17 2015 
    One Capital Management Cuts Stake in General Electric Aug 06 2015 
    Daniel Loeb's Third Point Second Quarter Investor Letter Aug 03 2015 
    Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
    Pennsylvania Trust Co. Top Buys in Q2 2015 Jul 16 2015 

    More From Other Websites
    Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt... Sep 03 2015
    Allergan agrees to acquire AqueSys for $300 million Sep 03 2015
    5:16 pm Allergan to acquire AqueSys for a $300 mln cash upfront payment and regulatory approval and... Sep 03 2015
    Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt... Sep 03 2015
    Moody's: Outlook for global pharmaceutical industry shifts to positive on successful product... Sep 03 2015
    AstraZeneca Ties Up for FluMist, CAZ-AVI Scores; Shares Up Sep 03 2015
    The Next Blockbusters Could Be Balms For Aging Eyes Sep 03 2015
    Regeneron, Roche, Bayer, More Set Sights On Better Eye Drugs Sep 03 2015
    Ackman's Pershing Square hedge fund drops 9.2 percent in Aug Sep 02 2015
    Ackman's Pershing Square hedge fund drops 9.2 percent in Aug Sep 02 2015
    Ackman's Pershing Square hedge fund drops 9.2 percent in August Sep 02 2015
    Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil) Sep 02 2015
    Positive Phase III Results Demonstrate Efficacy Of Antibiotic Medicine AVYCAZ™... Sep 02 2015
    Allergan Buys Naurex, Boosts Mental Health Portfolio Sep 01 2015
    Hedge Funds Amass Substantial Positions in These Mega-Caps Sep 01 2015
    Oppenheimer's 10 Stocks to 'Buy on Weakness' Aug 31 2015
    Allergan Successfully Completes Naurex Acquisition Aug 31 2015
    4 IBD 50 Drugmakers Getting Lift From New Treatments Aug 29 2015
    Will Clinical Trial Firm Icon Pass This Market Test? Aug 28 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK